India Eco Summit: Issues with USFDA to drag on, says Ranbaxy - Business Standard
Rediff
India Eco Summit: Issues with USFDA to drag on, says Ranbaxy
Business Standard
Last year, the USFDA had banned 30 generic drugs produced at Ranbaxy's plants at Poanta Sahib (in Himachal Pradesh) and Dewas (in Madhya Pradesh) citing ...
Ranbaxy CEO:FDA Issues Will Take Long Time To ResolveWall Street Journal